Ying Sun

This inventor holds 40 USPTO granted patents and 4 published patent applications and 13 EPO patents, primarily in Antibody Drug Conjugates. Top assignees: Enanta Pharmaceuticals, Inc., Ambrx, Inc., Merck Sharp + Dohme Corp.. Active years: 2006-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ying Sun. Retrieved from https://idiyas.com/inventor/ying-sun-jpo7wgh7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 40 (Patent Applications = 4)

% Patents Active = 47.5

EPO Patents = 13 (Patent Applications = 22)

Average Co-Inventor Count = 6.7

ph-index = 8

Forward Citations = 299(Granted Patents)

Location History:

La Jolla, CA (US) (2012)
Waltham, MA (US) (2006 - 2016)
San Diego, CA (US) (2017 - 2024)

Company Filing History:

29 out of 299

Enanta Pharmaceuticals, Inc.

Merck Sharp + Dohme Corp.

where one patent can have more than one assignee

Years Active: 2006-2026

Loading Chart...

Areas of Expertise:

Antibody Drug Conjugates

Hepatitis C Protease Inhibitors

Folate Bioconjugates

Non-Natural Amino Acids

Macrocyclic Compounds

Quinoxalinyl Derivatives

Prostate-Specific Membrane Antigen

Phosphate Based Linkers

Tri-Peptide Inhibitors

Oximyl Derivatives

Bicyclic Erythromycin Derivatives

Spirocyclic Bicyclolides

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12622944 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives (2026-05-12),

2. 12377294 - Anti-CD3 antibody folate bioconjugates and their uses (2025-08-05),

3. 12037405 - Anti-CD70 antibody drug conjugates (2024-07-16),

4. 11510993 - Antibody drug conjugate for anti-inflammatory applications (2022-11-29),

5. 11459392 - Anti-CD70 antibody drug conjugates (2022-10-04),

6. 11420999 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives (2022-08-23),

7. 10954270 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives (2021-03-23),

8. 10800856 - Prostate-specific membrane antigen antibody drug conjugates (2020-10-13),

9. 10550190 - Phosphate based linkers for intracellular delivery of drug conjugates (2020-02-04),

10. 10208123 - Anti-CD70 antibody drug conjugates (2019-02-19),

11. 9796754 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives (2017-10-24),

12. 9526769 - Macrocylic oximyl hepatitis C protease inhibitors (2016-12-27),

13. 9309279 - Macrocyclic hepatitis C serine protease inhibitors (2016-04-12),

14. 8962551 - Quinoxalinyl derivatives (2015-02-24),

15. 8809264 - Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors (2014-08-19),

Title: Inventor Ying Sun: Pioneering Innovations in Waltham

Introduction: Ying Sun is a visionary inventor based in Waltham, MA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Ying Sun holds several patents in the areas of artificial intelligence, renewable energy, and advanced robotics, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Ying Sun has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Ying Sun has collaborated with top engineers, scientists, and researchers, fostering a culture of innovation and excellence in all his projects.

Conclusion: Ying Sun's passion for pushing the boundaries of technology and his relentless pursuit of innovation continue to inspire the next generation of inventors and entrepreneurs worldwide.

Profile summary based on public USPTO records.